low-BC Group for Cardiovascular Disease

"The parameters for admission to this research project necessitate that applicants must be between 45 and 60 years old. For the under 18s, there are currently 43 studies available while those above 65 have access to 499 trials."

"According to clinicaltrials.gov, this particular study is not presently looking for participants; the first posting was made on July 20th 2021 and it has since been updated on August 29th 2022. However, there are 565 additional clinical trials which currently require enrolment from volunteers."

"This medical trial is recruiting 60 adults between the ages of 45 and 60 who suffer from cardiovascular diseases. Additionally, these participants must be physically active less than 7 hours per week, abstain from exercise 24 hours before blood or stool tests and 12 hours prior to bone measurements, avoid dietary supplements for the duration of the study, stay away from foods high in anthocyanins and fermented dairy products with viable Bifidobacteria or Lactobacilli bacteria strains, have not been taking hormone replacement therapy (HRT) for at least one year leading up to this study's initiation date, willing to ingest a daily berry concentrate supplement"

"Our team at Power concluded that the safety of low-BC Group is moderately high, scoring it a 1 on our risk scale. This reflects its status as a Phase 1 trial, with limited data backing up both efficacy and security concerns."